Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a cost-effective, high-yield synthesis of tolvaptan intermediate with no special equipment or toxic reagents. Reduce production risks and costs for your API manufacturing.
Discover a novel indolocyclopentane synthesis method with >95% yield and 93% ee. Ideal for pharmaceutical R&D targeting PC-3 prostate cancer cells. Scale up with CDMO expertise.
Solve low-yield and harsh conditions in enamide synthesis. Our CDMO expertise scales this palladium-catalyzed method with 60-81% yields, reducing costs and supply chain risks for API manufacturing.
Solve C-H activation challenges in pharmaceutical intermediates with green protonic acid catalysis. 91% yield, no precious metals, and industrial scalability for R&D and procurement teams.
Solve supply chain risks for (2S,4R)-2-amino-4-methylnonanoic acid with this 8-step, high-yield synthesis. Achieve >99% optical purity at scale. Contact us for CDMO solutions.
Solve supply chain gaps for (2S)-2-amino-4-cyclopropylbutyric acid with novel Suzuki coupling. 99.4% purity, 91.6% yield, and no special equipment required for GMP production.
Discover how chiral phosphoric acid catalysis enables high-yield, enantioselective synthesis of axial chiral aryl indoles for cancer drug development and supply chain de-risking.
Solve low-yield indolopyrrolone synthesis challenges with rhenium-catalyzed C-H activation. Achieve 95%+ yields, broad substrate tolerance, and scalable production for your drug development.
Solve supply chain risks with this novel 2-chlorothiophene-5-formic acid synthesis. 99.8% purity, 82% yield, and minimal waste. Ideal for rivaroxaban API production.
Solve low-yield & heavy metal issues in ramipril intermediate production. 85-99% purity, 85-99% yield, eco-friendly process. Scale to 100 MT/yr with CDMO expertise.
Solve high-cost, low-yield issues in salicylic acid synthesis. Our CDMO expertise enables scalable, eco-friendly production with >90% yield and minimal purification steps.
Discover cost-effective 1H-indole-2-amide production using cobalt-catalyzed C-H activation. Reduce supply chain risks and 30% production costs vs noble metal methods for API synthesis.
Solve azacyclooctanofuranone synthesis challenges with iron-catalyzed one-pot method. Reduce costs, improve yield, and ensure green production for pharma R&D and procurement teams.
Discover high-purity axial chiral cyclopentenyl indole-naphthyl compounds with 99% ee for PC-3 cancer cell cytotoxicity. Optimize your drug development with scalable synthesis.
Discover how axial chiral bisindole catalysts with >95:5 er enable scalable asymmetric synthesis, reducing R&D costs and supply chain risks for pharmaceutical intermediates.
Overcome high costs and safety risks in 2-chloro-4-fluorobenzoic acid production. Our new Meerwein arylation method eliminates noble metals, reduces waste, and achieves >80% yield for saflufenacil synthesis.
Discover how metal-free photoredox catalysis enables high-yield, enantioselective synthesis of chiral thiochroman-4-ketones for anticancer drug development. Reduce supply chain risks and GMP compliance costs.
Discover how metal-free photoredox catalysis enables high-yield, enantioselective synthesis of chiral chroman-4-ones for anticancer drug development. Reduce supply chain risks and improve purity.
Solve bempedoic acid synthesis challenges with trityl-protected intermediate. 97.8% yield, no toxic reagents, scalable for GMP production.
Solve high-cost chiral synthesis challenges with this patent-validated method. Achieve >70% ee and 92% yield in mild conditions. Contact us for GMP-compliant production.